Plunkett Research Online: Dawnrays Pharmaceutical (Holdings) Lilmited

DAWNRAYS PHARMACEUTICAL (HOLDINGS) LILMITED (DWNYF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Dawnrays Pharmaceutical (Holdings) Ltd is a major drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The vast majority of Dawnrays’ revenue is derived from the Finished Drugs segment. Nearly all of the company’s sales are ge.....



Dawnrays Pharmaceutical (Holdings) Lilmited
Ticker: DWNYF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 338 Hennessy Road
Units 3001–02, 30th Floor, CNT Tower
Wanchai, Hong Kong

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Dawnrays Pharmaceutical (Holdings) Ltd is a major drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The vast majority of Dawnrays’ revenue is derived from the Finished Drugs segment. Nearly all of the company’s sales are ge.....See More See More

Auditor: Ernst & Young
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: